Renerve Limited RNV

ASX · Australia · Health Technology

AUD 0.0800+0.00 (+3.90%)

Market closed· Oct 1, 2026, 2:23 AM UTC· AUD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Renerve Limited RNV

ASX · Australia · Health Technology

AUD 0.0800+0.00 (+3.90%)

Market closed· Oct 1, 2026, 2:23 AM UTC· AUD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-11.11% · 6MFull-screen chart

Open AUD 0.0800High AUD 0.0800Low AUD 0.0800Close AUD 0.0800Volume 135.00K

Oct 1, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: AUD 0.0770
Day range: AUD 0.0800 – AUD 0.0800
52-week range: AUD 0.0680 – AUD 0.2200
Volume: 135.00K
Market cap: AUD 13.34M
Avg. volume (1Y): 246.07K

Performance

1 week

+14.29%

1 month

+3.90%

3 months

0.00%

6 months

-23.81%

Year to date

-27.27%

1 year

-40.74%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Biotechnology
Country: Australia
Exchange: ASX
Shares outstanding: 173.28M
ISIN: AU0000358616
Beta: 0.20

Technical view

Mixed

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceJun 01, 2026

ReNerve signs distribution agreement to expand into Hong Kong and Greater Bay Area

ReNerve Ltd (ASX:RNV, OTC:RNVEF) has executed a distribution agreement with Swedish Trading Company Limited (STC) to commercialise its NervAlign products across Hong Kong, Macau and the Greater Bay Area. The agreement follows ReNerve’s recently announced expanded product approval across the...

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.